Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion type Assertion NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_head.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion description "[Lapatinib combined with capecitabine is an active treatment option for women with refractory HER2-positive MBC, including those with progressive CNS disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion evidence source_evidence_literature NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion SIO_000772 20179708 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion wasDerivedFrom befree-20140225 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion wasGeneratedBy ECO_0000203 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.